Age-related macular degeneration: an update on treatment.
Age-related macular degeneration is a chronic disease leading to progressive central vision loss. It is the leading cause of irreversible blindness in the United States, most commonly affecting white Caucasians aged more than 55 years. Typical symptoms include decreased central vision, central scotoma, and metamorphopsia. Patients with acute loss of vision should be promptly referred to an ophthalmologist. New antiangiogenic therapies have significantly improved visual prognosis in these patients.
Gohel
Parin S
PS
University of Colorado School of Medicine, Department of Ophthalmology, Denver, CO, USA.
Mandava
Naresh
N
Olson
Jeffrey L
JL
Durairaj
Vikram D
VD
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000375:Aging / Q000502:physiology; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D017075:Laser Coagulation / Q000379:methods; D008268:Macular Degeneration / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D018570:Risk Assessment; D012607:Scotoma / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome; D015354:Vision, Low / Q000175:diagnosis / Q000209:etiology
D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors